Greenwich Rx recalls compounded glutathione over elevated endotoxin levels
The Texas 503A pharmacy says two patients needed emergency care after intravenous administration of a glutathione product not formulated for IV use.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 3 17:45 ETSource: Solomon's Words for the Wise
The wire
- 01Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, is voluntarily recalling specific lots of compounded glutathione to the consumer level over potential elevated endotoxin levels, announced October 1, 2026.
- 02Injectables with elevated endotoxin can cause fever, hypotension, inflammatory reactions, anaphylactic shock and death, a direct sterility-assurance concern for pharmacies and clinics sourcing compounded injectables.
- 03Two adverse reports involved emergency department care after IV use of a product not formulated for that route; lot-level scope and any FDA follow-up action are not detailed in the notice.
From the source
Read at solomonswords.netGreenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
IMMEDIATE RELEASE – Tomball, Texas – October 1, 2026 – Greenwich Rx , a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
